Gene · 3945
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,321 to 1,340 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of Autophagy by Glycolysis in Cancer. | Cancer Manag Res | 2020 | 33380833 | PubTator, text mining | PubMed |
| Characterization of New Proteomic Biomarker Candidates in Mucopolysaccharidosis Type IVA. | Int J Mol Sci | 2020 | 33379360 | PubTator, text mining | PubMed |
| Secret3D Workflow for Secretome Analysis. | STAR Protoc | 2020 | 33377056 | PubTator, text mining | PubMed |
| m5C RNA Methylation Primarily Affects the ErbB and PI3K-Akt Signaling Pathways in Gastrointestinal Cancer. | Front Mol Biosci | 2020 | 33365328 | PubTator, text mining | PubMed |
| How Autophagy Shapes the Tumor Microenvironment in Ovarian Cancer. | Front Oncol | 2020 | 33364196 | PubTator, text mining | PubMed |
| Sex Difference of Ribosome in Stroke-Induced Peripheral Immunosuppression by Integrated Bioinformatics Analysis. | Biomed Res Int | 2020 | 33354565 | PubTator, text mining | PubMed |
| Lactate Metabolism in Breast Cancer Microenvironment: Contribution Focused on Associated Adipose Tissue and Obesity. | Int J Mol Sci | 2020 | 33353120 | PubTator, text mining | PubMed |
| From miRNA Target Gene Network to miRNA Function: miR-375 Might Regulate Apoptosis and Actin Dynamics in the Heart Muscle via Rho-GTPases-Dependent Pathways. | Int J Mol Sci | 2020 | 33352947 | PubTator, text mining | PubMed |
| Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors. | Front Oncol | 2020 | 33324565 | PubTator, text mining | PubMed |
| Serum Proteomics Reveals Alterations in Protease Activity, Axon Guidance, and Visual Phototransduction Pathways in Infants With In Utero Exposure to Zika Virus Without Congenital Zika Syndrome. | Front Cell Infect Microbiol | 2020 | 33312964 | PubTator, text mining | PubMed |
| In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators. | PLoS Biol | 2020 | 33306668 | PubTator, text mining | PubMed |
| A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patients. | Cell Death Discov | 2020 | 33293514 | PubTator, text mining | PubMed |
| Metabolomics revealed the influence of breast cancer on lymphatic endothelial cell metabolism, metabolic crosstalk, and lymphangiogenic signaling in co-culture. | Sci Rep | 2020 | 33277521 | PubTator, text mining | PubMed |
| Establishing a mass spectrometry-based system for rapid detection of SARS-CoV-2 in large clinical sample cohorts. | Nat Commun | 2020 | 33273458 | PubTator, text mining | PubMed |
| Evaluation of total LDH and its isoenzymes as markers in preeclampsia. | J Med Biochem | 2020 | 33269027 | PubTator, text mining | PubMed |
| Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology. | Drug Des Devel Ther | 2020 | 33262572 | PubTator, text mining | PubMed |
| Glycometabolic rearrangements--aerobic glycolysis in pancreatic cancer: causes, characteristics and clinical applications. | J Exp Clin Cancer Res | 2020 | 33256814 | PubTator, text mining | PubMed |
| Peripheral Glycolysis in Neurodegenerative Diseases. | Int J Mol Sci | 2020 | 33255513 | PubTator, text mining | PubMed |
| Early Interim Chemotherapy Response Evaluation by F-18 FDG PET/CT in Diffuse Large B Cell Lymphoma. | Diagnostics (Basel) | 2020 | 33255487 | PubTator, text mining | PubMed |
| Reversibility of hAT-MSCs phenotypic and metabolic changes after exposure to and withdrawal from HCC-conditioned medium through regulation of the ROS/MAPK/HIF-1α signaling pathway. | Stem Cell Res Ther | 2020 | 33246501 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3945/papers?page=67